Month: March 2025

Norden Discovers Gold Mineralized Porphyry Intrusion Returning 4.26 g/t Gold 850 Metres East of Sunrise Mine at the Smart Creek Project, Montana

Written by Customer Service on March 3, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, March 03, 2025 (GLOBE NEWSWIRE) — Norden Crown Metals Corp. (“Norden Crown” or the “Company“) (TSXV:NOCR, Frankfurt; 03E) provides new assay results from reconnaissance mapping and sampling at the high-priority Sunrise Target at the Smart Creek Project located in western Montana, USA (Figure 1). The discovery of Gold mineralization sampled at surface 850 meters from the Sunrise Mine substantially increases the discovery potential of this target. Summary of Results:New discovery of gold-rich porphyry intrusions (4.26 g/t gold) 850m east of the historic Sunrise Mine. New porphyry target at Sunrise where historical mining reported grades of 6.22 g/t Au, 31.1 g/t Ag and 1.5% Cu1,2,3. High gold tenor in samples (3.2 g/t and 4.2 g/t gold) from the historic Sunrise Mine area. Confirmed...

Volaris Group Acquires Oceans HQ

Written by Customer Service on March 3, 2025. Posted in Mergers And Acquisitions.

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) — Volaris Group (Volaris) today announced the acquisition of Oceans HQ, a leading provider of a SaaS solutions for international ship registries. Oceans HQ joins forces with PDMS, a Volaris Group company and provider of digital solutions and services. The Oceans HQ ship registry product portfolio and their team, will now operate as part of PDMS. Headquartered in the UK, Oceans HQ has been working with maritime administrations for over 10 years serving customers including Gibraltar Maritime Administration and the Swiss Maritime Navigation Office. Their full suite of software products (OHQ Cloud) has been designed to support the daily operations of maritime registries from vessel registration and survey and inspections through to seafarer certification. PDMS already serves a number of leading...

First Busey Corporation Completes Acquisition of CrossFirst Bankshares, Inc. and CrossFirst Bank

Written by Customer Service on March 3, 2025. Posted in Mergers And Acquisitions.

CHAMPAIGN, Il. and LEAWOOD, Kan., March 03, 2025 (GLOBE NEWSWIRE) — First Busey Corporation (“Busey”) (NASDAQ: BUSE), the holding company for Busey Bank, announced today the completion of its acquisition by merger of CrossFirst Bankshares, Inc. (“CrossFirst”) (NASDAQ: CFB), the holding company for CrossFirst Bank, effective March 1, 2025. The transaction was previously jointly announced on August 27, 2024. Busey will operate CrossFirst Bank as a separate banking subsidiary of Busey until it is merged with Busey Bank, which is expected to occur in June 2025. At the time of the bank merger, CrossFirst Bank’s banking centers will become branches of Busey Bank and operate under the Busey brand, creating a premier full-service commercial bank serving clients from 77 locations across 10 states with combined total assets of approximately...

Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program

Written by Customer Service on March 3, 2025. Posted in Mergers And Acquisitions.

TORONTO, March 03, 2025 (GLOBE NEWSWIRE) — TORONTO, March 3, 2025 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, rare disorders, and medical countermeasures, is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”), dated February 28, 2025, to acquire the full rights to DiagnaMed Holdings Corp.’s (CSE: DMED) (OTCQB: DGNMF) (“DiagnaMed”) intellectual property (the “Acquired Assets”) pertaining to molecular hydrogen as potential treatments for neurological and mental health disorders (the “Acquisition”). The Acquired Assets will include all of the following:Provisional patent application with the U.S. Patent and Trademark Office outlining...

CN and Iowa Northern Railway Officially Join their Operations

Written by Customer Service on March 3, 2025. Posted in Mergers And Acquisitions.

MONTREAL, March 03, 2025 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) and Iowa Northern Railway Company officially joined their operations on March 1, 2025, as previously authorized by the U.S. Surface Transportation Board. With the closing of this transaction, CN and Iowa Northern can begin integrating their two railroads to better serve customers, the Iowa economy and communities along the network. “This additional investment in the United States underscores our dedication to delivering outstanding rail service while driving economic growth. CN customers and partners along this network will benefit from single-line service offering new options and access to new markets.” – Tracy Robinson, President and Chief Executive Officer, CN “Today we celebrate this important milestone, as we welcome the Iowa Northern team into our CN family...

Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

Multiple Clinical Readouts Due in 2025 SOLANA BEACH, Calif., March 03, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, or neurological conditions, today provided a business update and announced its financial and operational results for the fiscal year ended December 31, 2024. Business Highlights:ART26.12: Phase I study is on track for completion in Q2 2025. ART27.13: Initial data from the Phase 2 CAReS trial anticipated by the end of Q2 2025. ART12.11: Substantial progress has been made toward initiation of human studies with an oral solid dosage form in 2H 2025.“Each of our programs is slated to reach important clinical milestones in 2025,” said Gregory...

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced solid tumors; more than 90% of sites activated across the U.S., Europe, U.K., and Asia-Pacific; interim analysis data expected mid-2025Enrollment commenced in the MD Anderson Cancer Center investigator-initiated Phase 1b study evaluating rezatapopt monotherapy and in combination with azacitidine in patients with relapsed or refractory AML/MDS harboring a TP53 Y220C mutationCash, cash equivalents, and marketable securities of $183.3 million as of December 31, 2024 providing expected cash runway to end of 2026PRINCETON, N.J., March 03, 2025 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology clinical-stage company pioneering the...

Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones

Written by Customer Service on March 3, 2025. Posted in Earnings Releases And Operating Results.

Robust, Consistent Phase 3 Data and Real-World Evidence Outcomes Support ANX005 as Potential First Targeted Therapy for GBS; Pre-BLA Meeting Targeted for 1H 2025 Ahead of Planned Biologics License Application (BLA) Submission Established Groundbreaking Global Registration Path for ANX007 to be Potential First Vision-Preserving Treatment for Dry AMD with GA in Europe and U.S.; Topline Phase 3 ARCHER II Data Expected Second Half 2026 First-in-Kind Oral C1s Inhibitor POC Trial Ongoing with Dosing in Three Patients with Cold Agglutin Disease; Expanded ANX1502 Dataset to Include Up to Seven Patients Expected Mid-2025 Strong Balance Sheet with Cash, Cash Equivalents, and Short-term Investments of Approximately $312 Million as of December 31, 2024, and Anticipated Runway into Second Half 2026 BRISBANE, Calif., March 03, 2025 (GLOBE NEWSWIRE)...

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.08 Per Share for March 2025

Written by Customer Service on March 3, 2025. Posted in Dividend Reports And Estimates.

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) announced today a monthly distribution of $0.08 per share for March 2025. This distribution is payable to common stockholders on March 31, 2025 (as outlined in the table below). The Company declares distributions on a monthly basis, with its next distribution expected to be declared in early April. Payment of future distributions is subject to the approval of the Company’s Board of Directors, as well as meeting the covenants on the Company’s debt agreements and the terms of its preferred stock.Record Date /Ex-Date Payment Date Distribution Amount Return of Capital Estimate3/14/25 3/31/25 $0.08 75%(1)(1) This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character...

Ready Capital Corporation Reports Fourth Quarter 2024 Results and Declares First Quarter 2025 Dividends

Written by Customer Service on March 3, 2025. Posted in Dividend Reports And Estimates.

– GAAP LOSS PER COMMON SHARE FROM CONTINUING OPERATIONS OF $(1.80) –– DISTRIBUTABLE LOSS PER COMMON SHARE OF $(0.03) –– DISTRIBUTABLE EARNINGS PER COMMON SHARE BEFORE REALIZED LOSSES OF $0.23 –– DISTRIBUTABLE RETURN ON AVERAGE STOCKHOLDERS’ EQUITY BEFORE REALIZED LOSSES OF 7.1% –– DECLARED A QUARTERLY CASH DIVIDEND OF $0.125 PER SHARE OF COMMON STOCK AND OPERATING PARTNERSHIP UNIT FOR THE QUARTER ENDING MARCH 31, 2025 – NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) — Ready Capital Corporation (“Ready Capital” or the “Company”) (NYSE: RC), a multi-strategy real estate finance company that originates, acquires, finances, and services lower-to-middle-market (“LMM”) investor and owner-occupied commercial real estate loans, today reported financial results for the quarter ended...

Month: March 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals